openPR Logo
Press release

Acute Kidney Injury Therapeutics Analysis by Top key Players - Stealth BioTherapeutics, Alloksys Life Sciences B.V., and Angion Biomedica Corp

Acute Kidney Injury Therapeutics Analysis by Top key Players -

Acute kidney injury (AKI) or acute kidney failure is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time. The disease generally occurs as a complication of another serious disease and is more common in the geriatric population that suffers from various other diseases. The study analyzed that AKI therapeutics pipeline comprises approximately 40 drug candidates in different stages of development.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis/report-sample

Apart from trials for drug-based therapeutics for AKI, the ongoing trials for various medical devices, minimally invasive therapy, regenerative medicine, tissue engineering, patient care technology around intensive care, monitoring, and various diagnostic tools for early diagnosis of AKI, are also covered in the report.

There has been an increase in the number of patents approved for the development of drug candidates for the treatment of AKI. For instance, in October 2016, the USPTO issued U.S. Patent 9,464,114 to Arch BioPartners, entitled, “Peptides that Block Leukocyte Recruitment and Methods of Use”. This was the first patent issued protecting the composition and method of use for Metablok.

Browse report at: https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis

Most of the companies are developing innovative technologies for the synthesis or production of drug candidates for the treatment of AKI. For instance, Quark Pharmaceuticals Inc. is using an innovative technology platform for generation of chemically modified siRNA compounds and their delivery to the desired organs. These are particularly well-suited to exploit the potential of siRNA for therapeutic applications. Also, Silver Creek Pharmaceuticals Inc. is using smart growth factor technology platform for the development of growth factors that play an important role in development, maintenance of tissue homeostasis, and pathology of many disease states.

Some of the key players involved in the development of AKI therapeutics include Alloksys Life Sciences B.V., Stealth BioTherapeutics Inc., and Angion Biomedica Corp.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Kidney Injury Therapeutics Analysis by Top key Players - Stealth BioTherapeutics, Alloksys Life Sciences B.V., and Angion Biomedica Corp here

News-ID: 1330527 • Views:

More Releases from Prescient & Strategic Intelligence

Biobanking Services Market by Biobank Type, Service Type, Ownership, Application and Geography Forecast to 2024 - P&S Intelligence
Biobanking Services Market by Biobank Type, Service Type, Ownership, Application …
The global biobanking services market is expected to broaden during the forecast period, mainly on account of growing prevalence of chronic diseases, use of blood biomarkers in early detection of various types of cancersincreasing genomic research activities for studying diseases, growing trend of conserving cord blood stem cells of newborns, surging government and private funding to support regenerative medicine research, and growing need for cost-effective drug discovery and development. Download free
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealth, Cerner Corporation, IBM, eClinicalWorks, InterSystems, Epic
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealt …
The patient engagement solutions market for software is expected to reach $12.3 billion by 2023, registering a CAGR of 16.6% during the forecast period. Patient engagement software is increasingly being adopted by healthcare facilities, as it helps simplify complex patient health data and can also be customized according to requirements. Download free report sample at: https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample During the forecast period, the patient engagement solutions market is expected to witness the highest demand
Peptide Therapeutics Market 2024 with Top Key Players are Sanofi, Teva Pharmaceuticals, Novartis, Ipsen, Amgen, PolyPeptide Group
Peptide Therapeutics Market 2024 with Top Key Players are Sanofi, Teva Pharmaceu …
The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the peptide therapeutics market. Patent expiration of several peptide drugs in the coming years will create ample opportunities for the global
ER+ Breast Cancer Pipeline to Witness Huge R&D Investment in the Coming Years | Chipscreen Biosciences, Eli Lilly and Company, Genentech
ER+ Breast Cancer Pipeline to Witness Huge R&D Investment in the Coming Years | …
The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates in different stages of development. Download free report sample at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis/report-sample *Chemical Genomics-Based Discovery Platform for ER+ breast cancer drug development Chipscreen Biosciences, Ltd. is using chemo genomics approach for the development of their drug candidates in ER+ breast cancer. The approach connects small molecule structures to disease targets and therapeutic functions to accelerate the discovery process

All 5 Releases


More Releases for AKI

Acute Kidney Injury (AKI) Disease Treatment Market Size and Forecast US$31.600 b …
Acute kidney failure can be deadly and requires serious therapy. Nonetheless, intense kidney disappointment might be reversible. On the off chance that you're generally healthy, you might recuperate ordinary or almost typical kidney function. The Global Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2022 and is expected to grow at a CAGR of +1% over the forecast period to reach a market size of US$31.600
Acute Kidney Injury (AKI) Equipment Market global outlook and forecast 2021 -202 …
The Global Acute Kidney Injury (AKI) Equipment Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Acute Kidney Injury (AKI) Equipment makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and
Increasing Prevalence of Acute Kidney Injury (AKI) and Chronic Kidney Disease to …
The growing prevalence of kidney disorders is expected to be the major factor driving the growth of the drug-induced nephrotoxicity treatment market over the forecast period. Increasing geriatric who are more prone drugs toxicity is also one of the key factor which is driving the drug-induced nephrotoxicity treatment. For instance, more than 661,000 American have kidney failure and in 2013 more than 47,000 American died from kidney disease (source: National
Acute Kidney Injury (AKI) Market Pipeline Insight- (2025) High Growth Opportunit …
Acute Kidney Injury (AKI) Pipeline Insight, 2020" Report gives comprehensive overview Of Present Clinical Development Scenario And Growth Prospects Across The Acute Kidney Injury (AKI) Market. A Detailed Picture Of The Acute Kidney Injury (AKI) Pipeline Landscape Is Provided, Which Includes The Disease Overview And Acute Kidney Injury (AKI) Treatment Guidelines. A Better Understanding of Disease Pathogenesis Contributing To The Development Of Novel Therapeutics For Acute Kidney Injury (AKI). Get
Acute Kidney Injury (AKI) Therapeutics to Witness Significant Growth due to Posi …
AKI or acute kidney failure is a common medical condition reported among hospitalized patients, especially those with multiple comorbid conditions. AKI can occur due to various reasons including decreased renal perfusion, and obstruction of the urinary collecting system. Dehydration, abdominal pain, rise in blood pressure, mild back pain, and vomiting are some of the symptoms associated with the disease. Download free sample copy of report at: https://www.pharmaproff.com/request-sample/1253 AKI is diagnosed through various
Home Retailing in Portugal Market Show at 2.3% CAGR to 2022 | IKEA, Leroy Merlin …
Home Retailing in Portugal Market Shares Summary and Forecasts to 2022 "Home Retailing in Portugal, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Portugal retail environment. In addition, it analyzes the key consumer trends influencing Portugal home industry. In 2017, home sector sales in Portugal stood at 4.6 billion and are projected